carbamazepine has been researched along with Genetic Diseases, Inborn in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Genetic Diseases, Inborn: Diseases that are caused by genetic mutations present during embryo or fetal development, although they may be observed later in life. The mutations may be inherited from a parent's genome or they may be acquired in utero.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scheffer, IE | 1 |
Bhatia, KP | 1 |
Lopes-Cendes, I | 1 |
Fish, DR | 1 |
Marsden, CD | 1 |
Andermann, F | 1 |
Andermann, E | 1 |
Desbiens, R | 1 |
Cendes, F | 1 |
Manson, JI | 1 |
1 review available for carbamazepine and Genetic Diseases, Inborn
Article | Year |
---|---|
Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder.
Topics: Adolescent; Carbamazepine; Diagnosis, Differential; Diagnostic Errors; Epilepsy, Frontal Lobe; Femal | 1994 |